4/16/2008 10:45:42 AM
SCOTTSDALE, ARIZONA--(Marketwire - April 16, 2008) - Holmes Biopharma, Inc. (OTCBB: HLMB) announces the recent signing of a $1.2 million dollar contract with a large East Asian pharmaceutical company. The contract establishes Holmes Biopharma with another major multinational pharmaceutical company, generating substantial Phase I clinical trial revenue for the Omaha operation. Furthermore, this contract is a significant revenue source for Holmes Biopharma's Data Management Center in Toronto, Canada.
comments powered by